Christopher Antypas is currently serving as President at Asti's South Hills Pharmacy, a retail pharmacy that is pushing the boundaries of community pharmacy practice. A native of Pittsburgh, Chris earned his Doctor of Pharmacy from the University of Pittsburgh School of Pharmacy, and has extensive experience in a variety of pharmacy practice settings. In addition to his role at Asti's, he owns and operates 2 additional pharmacies in Pittsburgh, PA that each serve a unique patient population. His pharmacies include a specialty pharmacy that supports patients suffering from complex conditions by providing specialty therapies, as well as a long-term care pharmacy that services patients residing in a facility.
In addition to his experience as a business owner, manager, and clinician, Chris is practicing as a pharmacy consultant and adviser. He is presently the Director of Pharmacy Solutions for Henderson Brothers, Inc., an insurance and benefits brokerage/consulting firm in Pittsburgh. In this role, Chris helps to support large, self-funded employers manage their pharmacy benefit with thoughtful and innovative strategies.
Chris currently serves as a board member of the Pennsylvania Pharmacists Association and also sits on the advisory board for both Value Drug Company and Prescribe Wellness. He has been named as a Luminary for The Community Pharmacy Enhanced Service Network (CPESN) as well as The Pennsylvania Pharmacists Care Network (PPCN), and in this capacity, he is helping to reshape community pharmacy practice with innovation and cutting-edge pharmacy care. Known for his commitment to advance pharmacy practice, Chris has been invited to speak nationally and regionally on a variety of pharmacy topics. Chris was recently honored to be named the 2019 ‘Pharmacist of the Year’ by the Pennsylvania Pharmacists Association, and in October of 2020, Chris was named the 'Next Generation Pharmacist - Entrepreneur of the Year'.
Pharmacy has been a life's passion for Chris, and when he's not solving medication related problems, he enjoys every minute with his wife and 3 children in the South Hills of Pittsburgh.
Ron Bone is a consultant in the area of Pharmaceutical Traceability and is currently focusing on the implementation of the U.S. 2013 Drug Quality and Security Act. Ron retired from McKesson Corporation where he held the position of Senior Vice President, Distribution Support. His responsibilities included Regulatory Affairs and leading McKesson's product security initiatives through the use of electronic track and trace.
Ron spent 41 years with McKesson Corporation in various operations, sales and financial management positions. He was a member of the of the GS1 Process Oversight Committee, a member of the Leadership Teams of GS1 Global Healthcare and GS1 US Healthcare, and was a member of the Industry Relations Council for the Healthcare Distribution Management Association (HDMA). In 2008, Bone testified before the U.S. House of Representatives, Energy and Commerce Committee as an industry expert on anti-counterfeiting. In 2007, he was the recipient of HDMA’s Nexus Award, which is the industry’s highest honor recognizing leadership, exemplary service and professional excellence.
Ron received his BS and MBA degrees from San Jose State University.
Dr. Randy V. Bradley is an Associate Professor of Information Systems and Supply Chain Management in the Haslam College of Business at The University of Tennessee. He is also EVP, Digital Transformation in Life Sciences for Bio Supply Management Alliance (BSMA) and Principal Owner of RV Bradley, LLC. He holds a Ph.D. in Management of Information Technology and Innovation, an M.S. in Management Information Systems, and a B.S. in Computer Engineering, all from Auburn University. Dr. Bradley is a preeminent thought leader and highly sought-after speaker for professional and corporate conferences and events. Dr. Bradley has 20+ years of industry experience as a consultant and healthcare supply chain and IT strategist and researcher. His expertise includes digital business transformation, supply chain digitalization, and the strategic application of business analytics and IT in the supply chain, with an emphasis on the healthcare sector.
Special Agent Dan Burke started his federal law enforcement career with the IRS-Criminal Investigation Division in 1995. In 1997, he transferred to the U.S. Customs Service where he primarily investigated on-line child pornography, drug and financial investigations. In 2002, he was promoted to Supervisory Special Agent for U.S. Customs, which is now known as ICE’s-Homeland Security Investigations, where he managed a Financial Investigations Task Force. In 2005, Dan joined FDA’s Office of Criminal Investigations (OCI).
During his career, Dan has completed a number of successful cybercrime investigations spanning the globe and is also part of OCI’s cadre of digital forensics specialists. In 2012, Dan was promoted to Manager of the Cybercrimes Investigation Unit (CcIU) and also began the development of OCI’s international expansion and liaison efforts. In 2019, Dan was promoted to manager of the Cyber Operations Branch and currently oversees OCI’s Digital Forensics, Cybercrime Investigations and Technical Surveillance Units. Dan has attained a variety of certifications in the field of digital and cyber-forensics, is listed on the United Nations Security Council Roster of Experts and has testified before the U.S. Senate on behalf of the FDA. He holds a master's degree in Criminal Justice Administration from the University of Colorado-Denver where he is currently a member of their adjunct faculty.
As a Director at Geisinger Health, Kevin utilizes Lean Thinking to focus on magnifying the value and eliminating the waste in the core value streams. Kevin’s evangelistic leadership style and manufacturing-based operational expertise, combined with his information systems background, has allowed him to stimulate new thinking and promotion of process redesign in Geisinger’s supply chain information and care support delivery systems. He is a foundational leader with the Healthcare Transformation Group (HTG), the Community Advisory Board (CAB) for GS1 U.S. Healthcare, and now serving on the Board of the newly formed Partnership for DSCSA Governance (PDG).He is active on multiple GS1, AHRMM, ASCx12, and C4SCS workgroups.He has completed AHRMM’s Healthcare Supply Chain Leadership Institute and completed his master’s degree in Project Management. In his spare time, he and his wife Diane, support their two son’s passion for cooking, and auto and motorcycle restoration.
Bob Celeste’s deep understanding and knowledge of the healthcare supply chain, including current standards and technologies, along with his ability to harness his expertise and innovate around the complexities of track-and-trace implementation, serialization and regulatory compliance, has made him a trusted industry partner.
Along with his work with both state and federal regulators, Bob often serves as an advisor to the FDA, State Boards of Pharmacy and other governing organizations. Most recently he was tapped as an advisor to the USAID and international regulators on the identification and tracking of drugs and medical supplies.
Bob launched the Center for Supply Chain Studies in 2015 to continue his practice of utilizing strategic simulations to address the challenges and demands of the supply chain. His expertise extends across many industries, including pharmaceutical, consumer goods, fresh foods, aerospace, automotive, specialty chemicals and others.
Prior to founding the Center, Bob was Senior Director at GS1 US, where he worked with industry on standards-based, item-level traceability and was the lead in developing the first DSCSA implementation guideline.
Larry Cote is one of the nation’s foremost Drug Enforcement Administration (DEA) compliance attorneys. He focuses his practice on counseling clients across the spectrum of regulatory compliance and enforcement issues involving the Controlled Substances Act (CSA). Having spent six and a half years heading up a national law firm’s DEA Compliance and Litigation Practice Group, Larry took the practice to his own firm, Cote Law PLLC, in 2018. Immediately before his law firm tenure, Larry was associate chief counsel for the Diversion and Regulatory Litigation Section at DEA. In this position, he took a prominent role in many of DEA’s most significant enforcement actions and compliance efforts.
Janet Crenshaw Smith is cofounder and President of Ivy Planning Group (Ivy), a 31-year-old consulting and training company that specializes in diversity, strategy and change management. Ivy has been recognized as one of the Top 50 minority-owned companies by DiversityBusiness.com; Black Enterprise Magazine Emerging Company of the Year Finalist; and received the Working Woman Magazine Entrepreneurial Excellence Award. Ms. Smith was honored as one of the Top 25 Consultants by Consulting Magazine, Diversity Executive of the Year by the Minority Enterprise Advocate magazine, “Diversity Pioneer” by Profiles in Diversity Journal. Minority Business & Professionals Network, Inc. named Ms. Smith one of “Fifty Influential Minorities in Business”. Profiles in Diversity Journal featured her in its Women of Initiative issue naming her one of “47 Women Worth Watching.” She has testified before U.S. Congressional Subcommittees as an expert on performance, diversity and inclusion.
Ms. Smith is author of the popular 58 Little Things That Make a Big Impact: The MicroTrigger Book and The Diversity Action Book: 143 Things To Go Do. Smith is an engaging speaker and is frequently quoted in national publications on the topics of diversity, change management, and leadership. She and her husband are profiled in DreamMakers: Putting Vision & Values to Work, a book that chronicles how leading edge organizations are able to succeed and realize their vision and values. Janet and Gary Smith, founders of Ivy Planning Group, are profiled for building a premier strategy firm - one of the leading Black-owned consulting firms in the country.
Ms. Smith works directly with corporate CEOs, executive teams, agency administrators, and senior officials to build strategies, facilitate challenging discussions, and achieve the organization’s vision. Ivy’s clients include Healthcare Distribution Alliance (HDA), American Society of Association Executives (ASAE), Pharmaceutical Care Management Association (PCMA), American Red Cross, Purdue Pharma, ViiV Healthcare, Advocate Aurora Health, RWJBarnabas Health, JP Morgan Chase, MetLife, Nike, Sony Pictures, L’Oreal, Comcast, Consumer Finance Protection Board, National Institutes of Health, Food and Drug Administration, Nuclear Regulatory Commission, and U.S. Departments of Justice, Energy and Treasury.
A native of Chicago’s south side, Janet earned a Bachelor's degree from Harvard University in Psychology and Social Relations. She started her professional career at IBM Corporation where she held a number of marketing and management positions including Manager of Executive Consulting Services.
Ms. Smith has served on the Governing Group of the Women’s Business Enterprise National Council (WBENC), Vice Chair of the National Women’s Business Center, Association of African American Harvard Alumni (AAAHA), strategic planning board of the Rainbow PUSH/Wall Street Project, Vistage, SHRM, American Society for Training and Development (ASTD), VisArts Metropolitan Center for the Arts, The Strategic Leadership Forum, the International Society for Strategic Management and Planning, Women Presidents’ Organization (WPO), National Association of Women Business Owners, and Potomac Valley Chapter of Jack and Jill of America, Inc.